Department of Radiology, Thomas Jefferson University, Philadelphia, PA 19107 (M.T., C.E.W., A.L., K.N.).
Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, Pennsylvania (D.H.).
Acad Radiol. 2024 Jan;31(1):199-211. doi: 10.1016/j.acra.2023.07.001. Epub 2023 Jul 26.
Marked liver steatosis, steatohepatitis, and significant fibrosis are risk factors for unfavorable outcomes in non-alcoholic fatty liver disease (NAFLD). In this study, the diagnostic performance of attenuation coefficient (AC), liver stiffness (LS), and dispersion slope (DS) was evaluated separately and combined in the diagnosis of liver steatosis and fibrosis in NAFLD suspects using biopsy or magnetic resonance imaging (MRI) as a reference standard.
Seventy-four NAFLD suspects were prospectively imaged with an Aplio i800 ultrasound scanner (Canon Medical Systems, Tustin, CA). AC, LS, and DS measurements were obtained from the right liver lobe.
Thirty-four patients underwent liver biopsy, and 40 had MRI. There were 32 patients (43%) with liver steatosis and fibrosis (S + F), 22 (30%) with steatosis (S), 5 (7%) with fibrosis (F), and 15 (20%) with normal liver (N). Mean ACs were significantly higher in steatotic livers (n = 54) than in non-steatotic livers (n = 20) (P < 0.0001). LS and DS were significantly higher in patients with liver fibrosis (n = 37) compared to non-fibrotic livers (n = 37) (P = 0.0004 and P = 0.0002, respectively). In detecting (S + F), the area under the receiver operating characteristic curve (AUROCC) was 0.87 for combined ultrasound parameters of LS and AC (negative predictive value [NPV]: 75%, positive predictive value [PPV]: 77%, P < 0.0001). In detecting patients with liver steatosis and fibrosis stage ≥2, LS had an AUROCC of 0.93 (NPV: 87%, PPV: 82%, P < 0.0001). In the biopsy group, 32% (11/34) were diagnosed with non-alcoholic steatohepatitis (NASH). DS values showed a significant difference among patients with (n = 23) or without (n = 11) hepatocellular ballooning (P = 0.02). AUROCC was 0.87 for combined ultrasound parameters of AC, LS, and DS with body mass index (BMI) in detecting NASH (NPV: 80%, PPV: 87%, P = 0.0006).
AC and LS showed high diagnostic value in detecting liver steatosis and fibrosis, respectively. The combined AC and LS values further improved the diagnostic accuracy in detecting NAFLD and high-risk NAFLD patients.
明显的肝脂肪变性、脂肪性肝炎和显著的纤维化是非酒精性脂肪性肝病(NAFLD)不良结局的危险因素。本研究旨在评估衰减系数(AC)、肝硬度(LS)和弥散斜率(DS)在使用肝活检或磁共振成像(MRI)作为参考标准诊断 NAFLD 疑似患者肝脂肪变性和纤维化中的诊断性能。
74 例 NAFLD 疑似患者前瞻性地使用 Aplio i800 超声扫描仪(佳能医疗系统公司,加利福尼亚州塔斯汀)进行成像。AC、LS 和 DS 测量均取自右肝叶。
34 例患者行肝活检,40 例行 MRI 检查。32 例(43%)患者有肝脂肪变性和纤维化(S+F),22 例(30%)有脂肪变性(S),5 例(7%)有纤维化(F),15 例(20%)有正常肝脏(N)。脂肪变性肝脏(n=54)的平均 AC 值明显高于非脂肪变性肝脏(n=20)(P<0.0001)。有肝纤维化的患者(n=37)的 LS 和 DS 值明显高于无纤维化的患者(n=37)(P=0.0004 和 P=0.0002)。在检测(S+F)时,LS 和 AC 联合超声参数的受试者工作特征曲线下面积(AUROCC)为 0.87(阴性预测值[NPV]:75%,阳性预测值[PPV]:77%,P<0.0001)。在检测肝脏脂肪变性和纤维化≥2 期的患者中,LS 的 AUROCC 为 0.93(NPV:87%,PPV:82%,P<0.0001)。在肝活检组中,32%(11/34)被诊断为非酒精性脂肪性肝炎(NASH)。DS 值在有(n=23)或无(n=11)肝细胞气球样变的患者之间存在显著差异(P=0.02)。AC、LS 和 DS 联合体质量指数(BMI)的 AUROCC 为 0.87,用于检测 NASH(NPV:80%,PPV:87%,P=0.0006)。
AC 和 LS 在检测肝脂肪变性和纤维化方面具有较高的诊断价值。AC 和 LS 值联合进一步提高了检测 NAFLD 和高危 NAFLD 患者的诊断准确性。